Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus

Authors
Jochimsen, EM Luo, CC Beltrami, JF Respess, RA Schable, CA Cardo, DM
Citation
Em. Jochimsen et al., Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus, ARCH IN MED, 159(19), 1999, pp. 2361-2363
Citations number
10
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ARCHIVES OF INTERNAL MEDICINE
ISSN journal
00039926 → ACNP
Volume
159
Issue
19
Year of publication
1999
Pages
2361 - 2363
Database
ISI
SICI code
0003-9926(19991025)159:19<2361:IOPFOP>2.0.ZU;2-B
Abstract
Information suggesting that zidovudine postexposure prophylaxis (PEP) reduc es the risk of human immunodeficiency virus (HIV) transmission after occupa tional exposure to HIV-infected blood prompted the US Public Health Service to provide guidelines for the use of combination drug therapy for chemopro phylaxis after certain occupational exposures to HIV.(1,2) Many health care workers (HCWs) worldwide may take PEP following occupational exposures to HIV.